Skip to main content
Laurus Labs Limited logo

Laurus Labs Limited — Investor Relations & Filings

Ticker · LAURUSLABS ISIN · INE947Q01028 LEI · 335800S8HO8QRYP3VQ26 BSE.NS Manufacturing
Open in API
Filings indexed 707 across all filing types
Latest filing 2026-05-29 Regulatory Filings
Country IN India
Listing BSE.NS LAURUSLABS

About Laurus Labs Limited

https://www.lauruslabs.com/

Laurus Labs Limited is a research-driven organization focused on the development and manufacturing of active pharmaceutical ingredients (APIs), finished dosage forms (FDF), and specialized synthesis services. The company operates across several key therapeutic areas, including anti-retroviral (ARV), oncology, cardiovascular, and anti-diabetic treatments. Through its contract development and manufacturing organization (CDMO) division, it provides integrated drug development solutions to global partners. The company also maintains a biotechnology segment dedicated to recombinant products. Leveraging advanced research and development capabilities alongside large-scale manufacturing infrastructure, the firm emphasizes process chemistry innovation and cost-efficient production to serve diverse global healthcare markets.

Recent filings

Filing Released Lang Actions
Please see annexed enclosure.
Regulatory Filings Classification · 85% confidence The document is a formal intimation under Regulation 30 of SEBI Listing Obligations, notifying stock exchanges of scheduled investor/analyst meetings. It does not present financial results, solicit votes, or provide a full report. It is a compliance announcement rather than the substance of a report itself. This falls under general regulatory announcements and compliance disclosures, which is classified as Regulatory Filings (RNS).
2026-05-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 80% confidence The document is an intimation pursuant to SEBI Listing Regulations about the schedule of analyst / institutional investor meetings. It is a notification to stock exchanges under Regulation 30, not the content of any financial report or presentation itself. Therefore, it is a regulatory announcement (miscellaneous compliance filing) rather than an investor presentation or financial report.
2026-05-29 English
Please see enclosed annexure.
Regulatory Filings Classification · 92% confidence The document is a compliance certificate (“Annual Secretarial Compliance Report”) issued by a Practicing Company Secretary to stock exchanges under SEBI LODR Regulations. It contains no financial statements but is an attestation/certification of regulatory compliance. Under the instructions, officer certifications and regulatory compliance reports should be classified as Regulatory Filings (RNS).
2026-05-26 English
Please see annexed enclosure.
Regulatory Filings Classification · 91% confidence The document is an intimation pursuant to SEBI Listing Regulations disclosing the schedule of analyst and investor meetings. It is a regulatory disclosure to stock exchanges rather than a financial report, management discussion, or presentation itself. It does not contain financial data, vote results, or a report, but serves as a continuous disclosure announcement. Therefore, it falls under the general Regulatory Filings category (RNS).
2026-05-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 85% confidence The document is a compliance notification under SEBI LODR Regulation 30 informing stock exchanges of upcoming analyst/institutional investor meetings. It does not contain financial statements, dividend info, capital changes, or the full investor presentation itself—rather it is a general regulatory announcement. No specific filing category (e.g., earnings release, IR, IP) fits this scheduling notice, so it belongs in the fallback category for miscellaneous regulatory disclosures.
2026-05-21 English
Please see annexed enclosure.
Regulatory Filings Classification · 82% confidence The document is a brief notification to stock exchanges announcing inclusion in the Dow Jones Best-in-Class ESG index. It does not contain substantive financial data, a report, or dividend details, nor is it an AGM/EGM voting result or management change. It’s a general regulatory announcement, fitting the fallback category Regulatory Filings (RNS).
2026-05-21 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.